St. Jude Medical founder Manny Villafaña’s Medical 21 filed an amendment to an SEC Form D to reveal that it raised more than $1.1 million in an equity offering. The Minneapolis-based company raised a total of $1.14 million in a $10 million offering, leaving $8.86 million remaining to be sold, according to the SEC filing. […]
Nanox Imaging raises $26m
Nanox Imaging announced today that it secured $26 million in funding in support of the development, commercialization and deployment of its Nanox System for early detection of medical conditions. With participation from strategic investor Foxconn, along with Fujifilm (TSE:4901), SK Telecom and other private investors, Neve Ilan, Israel-based Nanox said its total funding is now at […]
Proteus pivots, hands digital mental health adherence business to Otsuka
Proteus Digital Health is abandoning its mental illness and cardiovascular work in its digital pill technology after its deal with Otsuka Pharmaceutical (TYO:4578) ended prematurely and will start to focus more on therapeutic areas, STAT News reports. Otsuka Pharmaceutical had been paying Proteus to develop a portfolio of digital medicines for serious mental health conditions. […]
Embody lands $2.5m from DARPA
Soft-tissue repair treatment developer Embody announced that it has landed a $2.5 million grant from the Defense Advanced Research Projects Agency (DARPA). The latest DARPA funding brings Norfolk, Va.-based Embody’s total DARPA non-dilutive funding to nearly $14.4 million, according to a news release. Embody plans to use the Phase II Small Business Innovation Research (SBIR) […]
Reva Medical files for bankruptcy
Reva Medical (ASX:RVA) announced today that it has filed for Chapter 11 bankruptcy protection. San Diego-based Reva — which specializes in bioresorbable polymer tech for vascular applications — entered into a restructuring support agreement with a handful of its stakeholders last month. The goal was to address the company’s outstanding debt. Reva also filed a prepackaged […]
Medicrea looking for a buyer
Medicrea (EPA:ALMED) announced that it is engaged in active discussions with potential strategic partners in the U.S. spine industry as it seeks to execute an agreement resulting in a company takeover, partnerships or distribution agreements. The company said that leading U.S. groups have made regular approaches to share industry developments and review potential strategic partnerships around […]
LumiThera closes second Series C financing round
LumiThera announced today that it closed the second tranche of its Series C financing round with more than $10 million raised. The photobiomodulation (PBM) treatment developer earmarked the proceeds from the funding round for further clinical testing and commercialization of its Valeda light delivery system for treating dry age-related macular degeneration (AMD). LumiThera’s Valeda system […]
Abbott boosts support for Bigfoot Biomedical and its diabetes treatment tech
Diabetes treatment tech company Bigfoot Biomedical has raised another $45 million in the initial tranche of a Series C equity financing, with collaborator Abbott (NYSE:ABT) as the lead investor. “We are excited to announce Abbott’s deepening support of Bigfoot Biomedical with this Series C financing,” Bigfoot Biomedical CEO Jeffrey Brewer said in a news release today. […]
Cardiologs raises $15m for its AI cardiology diagnostics
Artificial intelligence cardiology diagnostics company Cardiologs Technologies announced that it raised $15 million in a Series A funding round. The round, led by Paris-based venture capital firm Alven, brought Boston-based Cardiologs’ total capital raised since inception to more than $25 million, according to a news release. Bpifrance, ISAI, Kurma Diagnostics, Idinvest Partners and Paras Saclay […]
SeaSpine announces public offering
Spinal disorder treatment developer SeaSpine Holdings (NSDQ:SPNE) announced that it commenced an underwritten public offering of shares of its common stock. The Carlsbad, Calif.–based company plans to use the proceeds from the offering for working capital and other general corporate purposes. All shares in the offering are slated to be sold by SeaSpine. Piper Sandler and […]
Virtual Incision raises $20m for MIRA surgical robot
Virtual Incision announced today that it raised $20 million in a Series B financing round for its MIRA (miniaturized in vivo robotic assistant) surgical robotic platform. The company also filed for an FDA investigational device exemption for the MIRA platform so it can initiate a clinical study in support of its regulatory pathway to approval. […]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 202
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube